COVID-19 Real Time Learning Network

The Latest: What You Need to Know

FDA to Meet June 15 to Discuss COVID-19 Vaccines for Young Children

FDA’s Vaccines and Related Biological Products Advisory Committee will meet June 15 to review EUA requests for Moderna and Pfizer-BioNTech COVID-19 vaccines for children under the age of five.

VISIT WEBSITE

ACP COVID-19 Forum: Management of Patients With Persistent Symptoms After COVID-19

Tomorrow, Tuesday, May 24, the American College of Physicians will hold a virtual panel discussion on challenges related to caring for long COVID patients.

VISIT WEBSITE

Pfizer-BioNTech Announce Third-Dose Data for Children 6 Months–5 Years, Will Submit to FDA for Emergency Authorization

In this press release, the companies announce they will submit Phase 2/3 data to FDA this week indicating high efficacy and tolerance of a third 3-µg dose in children 6 months to under 5 years of age.

VISIT WEBSITE

23 May, 2022

Podcast: The Latest on COVID-19 Vaccine Boosters

IDSA podcast featuring clinicians reviewing latest recommendations on COVID-19 boosters.

PLAY MEDIA

21 May, 2022

IDSA Media Briefing: Paxlovid Use and Availability

Video recording of IDSA experts discussing practice guidelines on nirmatrelvir/ritonavir (Paxlovid), drug interactions and current availability.

PLAY MEDIA

20 May, 2022

CDC Recommends COVID-19 Vaccine Boosters for Children Aged 5 to 11

CDC has expanded eligibility for COVID-19 boosters to include everyone at least five years of age, recommending that children between the ages of five and 11 receive a booster shot five months after their initial Pfizer-BioNTech vaccination series.

VISIT WEBSITE

19 May, 2022

Featured Resources

IDSA/CDC COVID-19 Clinician Call

CDC Clinician Hotline

Clinicians are waiting on standby to answer your COVID-19 questions. Dial 1-800-CDC-INFO.

Podcast

IDSA's COVID-19: What's Happening Now podcast keeps listeners informed with expert analysis.

Events

Our directory of digital/virtual events and learning opportunities for the COVID-19 Real-Time Learning Network community.

Shareable Resources

Pregnancy and the COVID-19 Vaccine

Tixagevimab & Cilgavimab (Evusheld™) Point-of-Care Reference

COVID-19 Outpatient Treatment Guidelines Roadmap

Molnupiravir Quick Point-of-Care Reference

COVID-19, Myocarditis, and Vaccines

Long COVID Patient Fact Sheet

Nirmatrelvir/Ritonavir (Paxlovid™) Point-of-Care Reference

Ivermectin & COVID-19

COVID-19 Variants

Pregnancy & COVID-19

Latest Multimedia

The Latest on COVID-19 Vaccine Boosters (May 21, 2022)

5/21/2022

IDSA Media Briefing: Paxlovid – Updates on Its Use and Availability

5/20/2022

Cultural Awareness Series: Asian American and Pacific Islander Heritage Month, Part 3 — The Impact of the COVID-19 Pandemic on Patients and Providers

5/17/2022

The Latest on COVID-19 Vaccine Boosters (May 21, 2022)

5/21/2022

IDSA Media Briefing: Paxlovid – Updates on Its Use and Availability

5/20/2022

Cultural Awareness Series: Asian American and Pacific Islander Heritage Month, Part 3 — The Impact of the COVID-19 Pandemic on Patients and Providers

5/17/2022

About the COVID-19 Real-Time Learning Network

The COVID-19 Real-Time Learning Network is a curated repository of clinical guidance, emerging research, and practice management tools to support clinicians of all backgrounds. With funding from the Centers for Disease Control and Prevention and guidance from a multidisciplinary Advisory Group, this site is updated daily with must-have information for clinicians and decision-makers.